cilostazol

Generic: cilostazol

Labeler: direct rx
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name cilostazol
Generic Name cilostazol
Labeler direct rx
Dosage Form TABLET
Routes
ORAL
Active Ingredients

cilostazol 50 mg/1

Manufacturer
direct rx

Identifiers & Regulatory

Product NDC 72189-116
Product ID 72189-116_2be8fd92-0c90-d751-e063-6394a90af165
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA077027
Listing Expiration 2026-12-31
Marketing Start 2020-12-02

Pharmacologic Class

Established (EPC)
phosphodiesterase 3 inhibitor [epc]
Mechanism of Action
phosphodiesterase 3 inhibitors [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 72189116
Hyphenated Format 72189-116

Supplemental Identifiers

RxCUI
242462
UNII
N7Z035406B
NUI
N0000175598 N0000175086

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name cilostazol (source: ndc)
Generic Name cilostazol (source: ndc)
Application Number ANDA077027 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 50 mg/1
source: ndc
Packaging
  • 60 TABLET in 1 BOTTLE (72189-116-60)
source: ndc

Packages (1)

Ingredients (1)

cilostazol (50 mg/1)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "2be8fd92-0c90-d751-e063-6394a90af165", "openfda": {"nui": ["N0000175598", "N0000175086"], "unii": ["N7Z035406B"], "rxcui": ["242462"], "spl_set_id": ["b57d3c1e-e36f-5255-e053-2a95a90ada83"], "pharm_class_epc": ["Phosphodiesterase 3 Inhibitor [EPC]"], "pharm_class_moa": ["Phosphodiesterase 3 Inhibitors [MoA]"], "manufacturer_name": ["direct rx"]}, "finished": true, "packaging": [{"sample": false, "description": "60 TABLET in 1 BOTTLE (72189-116-60)", "package_ndc": "72189-116-60", "marketing_start_date": "20201202"}], "brand_name": "CILOSTAZOL", "product_id": "72189-116_2be8fd92-0c90-d751-e063-6394a90af165", "dosage_form": "TABLET", "pharm_class": ["Phosphodiesterase 3 Inhibitor [EPC]", "Phosphodiesterase 3 Inhibitors [MoA]"], "product_ndc": "72189-116", "generic_name": "CILOSTAZOL", "labeler_name": "direct rx", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "CILOSTAZOL", "active_ingredients": [{"name": "CILOSTAZOL", "strength": "50 mg/1"}], "application_number": "ANDA077027", "marketing_category": "ANDA", "marketing_start_date": "20201202", "listing_expiration_date": "20261231"}